Skip to main content

PolyPid Ltd.

PYPD
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001611842

No open-market purchases or sales by PolyPid Ltd. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $16.7M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding PolyPid Ltd. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of PYPD: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders1927+8
Shares1.53M1.52M−11.3K (−0.7%)
Value$11.9M$8.71M−$3.19M (−26.8%)

New holders (9)

Institutions that held PolyPid Ltd. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to PYPD in Q4 2021
InstitutionSharesValue% of portfolio
Barclays PLC71,000$408.0K0.00%
Susquehanna International Group, LLP25,319$145.0K0.00%
Simplex Trading, LLC15,577$89.0K0.00%
Virtu Financial LLC13,611$78.0K0.01%
Citadel Advisors LLC12,204$70.0K0.00%
Advisor Group Holdings, Inc.10,000$57.0K0.00%
Bank of America Corp9,189$52.0K0.00%
Wells Fargo & Company782$4.00K0.00%
Harel Insurance Investments & Financial Services Ltd.497$3.00K0.00%

Sold out (1)

Institutions that held PolyPid Ltd. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of PYPD in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
1623 Capital LLC11,627$90.0K